What is the IM (intramuscular) dose of atropine in a pediatric patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IM Atropine Dosing in Pediatric Patients

The intramuscular dose of atropine in pediatric patients is 0.01 mg/kg (10 mcg/kg), not to exceed 0.4 mg per dose, administered subcutaneously or intramuscularly every 4-6 hours for antimuscarinic indications. 1

Standard IM Dosing by Weight

The FDA-approved dosing for intramuscular administration in children is weight-based and indication-specific 1:

Antimuscarinic Indications

  • General pediatric dose: 10 mcg/kg (0.01 mg/kg) subcutaneous or IM, maximum 400 mcg (0.4 mg) per dose 1
  • Alternative calculation: 300 mcg (0.3 mg) per square meter of body surface area 1
  • Frequency: Every 4-6 hours as needed 1

Preanesthesia (Antisialagogue/Antiarrhythmic) - Subcutaneous Dosing

For surgical premedication, weight-stratified dosing is recommended 1:

  • Up to 3 kg: 100 mcg (0.1 mg)
  • 7-9 kg: 200 mcg (0.2 mg)
  • 12-16 kg: 300 mcg (0.3 mg)
  • 20-27 kg: 400 mcg (0.4 mg)
  • 32 kg: 500 mcg (0.5 mg)
  • 41 kg: 600 mcg (0.6 mg)

Emergency/Toxicological Indications (IM Route)

Organophosphate Poisoning

  • Initial dose: 0.02-0.05 mg/kg IV preferred, but IM acceptable when IV access unavailable 2
  • Maximum single dose: 2-3 mg 2
  • Repeat dosing: Every 5-10 minutes until muscarinic symptoms resolve 1
  • Pediatric-specific consideration: For nerve agent exposure, start at 0.02 mg/kg, with cumulative doses potentially much higher than standard 2

Critical caveat: In organophosphate poisoning, do not withhold adequate atropine doses due to fear of overdose—inadequate dosing can be fatal 2. Adult patients may require 10-20 mg in the first 2-3 hours, and up to 50 mg in 24 hours 2.

Mushroom Poisoning (Muscarine)

  • Dose: 1-2 mg IM or IV every hour until respiratory effects subside 1

Important Clinical Considerations

Route Selection

  • IM administration is acceptable when IV/IO access is unavailable or delayed 1
  • IV/IO is preferred for acute bradycardia (0.02 mg/kg) and organophosphate poisoning due to faster onset 2, 3
  • Endotracheal route can be used as last resort: 0.01-0.03 mg/kg for neonates, 0.03-0.06 mg/kg for older children, followed by saline flush 2

Safety Warnings

  • Concentration errors are common: Atropine comes in different concentrations—calculate doses carefully to avoid 10-fold errors 2
  • Minimum dose controversy: Recent American Heart Association guidelines (2015) eliminated the 0.1 mg minimum dose requirement for neonates, as 0.02 mg/kg without minimum is effective and safe 3
  • Monitor for tachycardia: Excessive heart rate could worsen ischemia in patients with underlying cardiac conditions 2, 3

Common Pitfalls to Avoid

  • Do not use IM atropine for acute symptomatic bradycardia when IV/IO access is available—IV route provides faster action 2, 3
  • Do not routinely premedicate all pediatric intubations with atropine—it is only indicated for high-risk situations (succinylcholine use, age 28 days to 8 years, septic shock) 4
  • Do not use atropine for type II second-degree or third-degree AV block with wide-complex escape rhythm—it is ineffective and potentially harmful 2

References

Guideline

Atropine Dosing in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Atropine Dosing for Bradycardia in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Atropine Pretreatment in Pediatric Intubation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.